Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole for Refractory Bipolar and Unipolar Depression
NCT00335205Phase 4Unknown
- Sponsor
- Sheba Medical Center
- Start
- Apr 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bipolar disorder (BD) and major depressive disorder (MDD) comparing Ropinirole with Placebo (2 arms). Primary endpoint: Hamilton Depression Rating Scale at 7 weeks. Status: unknown.
02
Drugs
ropinirole
03
Conditions
bipolar disorder (BD)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00335205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00335205.